VEGFA and neoplasm: Along with scFv, other tumor-binding moieties including an anti-integrin peptide α5β6 (82), heregulin (83), interleukin 13-zetakine (84), NKG2D (85), vasculature endothelial growth factor (VEGF) (86), and TCRs (87) have been incorporated into functional CARs.